Immune memory shapes ovarian cancer recurrence

Analisa DiFeo · 2025-07-31

Despite current progress, many patients with ovarian cancer (OC) often relapse after therapy. In this issue of Cancer Cell, Ghisoni et al. integrate multiomic and functional analyses to provide a roadmap for biomarker-driven therapy in OC and suggest that immune phenotyping could be incorporated into clinical stratification.
TL;DR

Multiomic and functional analyses are integrated to provide a roadmap for biomarker-driven therapy in OC and immune phenotyping could be incorporated into clinical stratification and it is suggested that immune phenotyping could be incorporated into clinical stratification.

AI-generated by Semantic Scholar

Authors
Analisa DiFeo